Stay updated on Empagliflozin US Comparative Effectiveness Clinical Trial

Sign up to get notified when there's something new on the Empagliflozin US Comparative Effectiveness Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Empagliflozin US Comparative Effectiveness Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.8.0 to v3.8.1, while the study information remains unchanged.
    Difference
    0.1%
    Check dated 2026-11-21T14:43:26.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the EMPRISE study is available again, describing its real-world comparison of empagliflozin and other diabetes treatments, study measures, and completed status.
    Difference
    47%
    Check dated 2026-11-07T14:20:09.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.8.0 instead of v3.7.2. The page continues to show a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-31T15:02:09.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error response; the study record remains inaccessible.
    Difference
    1%
    Check dated 2026-10-24T16:18:18.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The revision label in the footer changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T16:09:57.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The study page continues to show a 403 Forbidden error instead of a study record, with the footer showing revision v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T16:07:52.000Z thumbnail image

Stay in the know with updates to Empagliflozin US Comparative Effectiveness Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Empagliflozin US Comparative Effectiveness Clinical Trial page.